Abstract
In Brazil, estimates of incidence and mortality in 2016 from National Cancer Institute (INCA) show that this neoplasm should reach 28,220 people, including 17,330 males 10,890 females. There is an urgency to develop new noninvasive diagnostic methods for greater comfort and less patient anxiety. Amid this scenario, several research groups have invested deeply in the search for biomarkers …